NovoLabs
Innovative UV disinfection solutions for ultra low UV transmittance liquids with modular systems for diverse applications.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
* | $1.0m Valuation: $14.3m | Seed | |
| Total Funding | 000k | ||
NovoLabs specializes in bespoke ultraviolet (UV) disinfection solutions, focusing on liquids with low clarity and low UV transmittance. The company has developed a patented supercritical UV device designed to disinfect a wide range of liquids and flow rates. NovoLabs serves businesses across various industries that require specialized liquid disinfection solutions. Operating primarily in the UV disinfection market, NovoLabs adopts a business-to-business (B2B) model, generating revenue through the sale and customization of its modular UV systems. The company's core clients include industries dealing with complex liquid disinfection needs, such as water treatment facilities, beverage manufacturers, and healthcare providers. NovoLabs stands out by offering tailored solutions that meet the unique requirements of each client, ensuring optimal performance and compliance with industry standards.
Keywords: UV disinfection, supercritical UV device, liquid treatment, low UV transmittance, modular systems, bespoke solutions, B2B, water treatment, healthcare, innovation.